查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946603

2026年全球神经栓塞器材市场报告

Neurovascular Embolization Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经血管栓塞器械的市场规模显着成长，预计将从2025年的13.8亿美元成长到2026年的14.7亿美元，复合年增长率为6.2%。过去几年的增长可归因于多种因素，例如脑动脉瘤发病率的上升、介入神经放射学手术的普及、熟练的神经血管专科医生数量的增加、医院对先进神经科护理投入的增加以及微创卒中治疗方法的日益普及。

预计未来几年，神经血管栓塞器械市场将维持强劲成长，到2030年市场规模将达到19.1亿美元，复合年增长率（CAGR）为6.8%。预测期内的成长要素包括：对先进中风治疗方案的需求不断增长、神经血管研发投入增加、血管疾病患者老化加剧、新一代栓塞器械的广泛应用以及对改善手术效果的日益重视。预测期内的主要趋势包括：血流晶粒支架的广泛应用、液体栓塞系统的使用日益普及、微创介入神经放射学介入治疗的日益受到青睐、先进涂层弹簧圈技术的推广以及对精准神经血管器械的日益关注。

出血事件发生率的上升预计将推动神经血管栓塞器械市场扩张。出血是指体内异常且无法控制的出血，或因皮肤或黏膜破损导致的体外异常出血。导致出血事件高发生率的因素包括人口老化、高血压盛行率上升以及抗凝血剂的广泛使用。神经血管栓塞器械在治疗出血性中风中发挥至关重要的作用，因为它们可以透过阻塞异常血管来控制出血并防止进一步的脑损伤。例如，伦敦国王学院最近的一项研究预测，到2050年，英国70至95岁人群中脑出血（一种特定类型的出血）的病例数和死亡人数将增加59.4%。因此，出血事件的增加趋势正在推动神经血管栓塞器械市场的成长。

神经血管栓塞器械市场的主要企业正致力于开发先进的解决方案，例如新一代血流导引装置，以取代传统的动脉瘤治疗方法。新一代血流导向装置旨在透过提高与血管壁的黏附性、降低血栓风险以及即使在复杂的动脉瘤解剖结构中也能更轻鬆地部署，从而增强手术的安全性和有效性。例如，2025年7月，美国医疗技术公司史赛克(Stryker)宣布推出其神经血管产品组合中的Surpass 精英血流导向装置。这款创新装置透过为大型或巨大未破裂脑动脉瘤提供微创血流导向疗法，取代了传统的动脉瘤治疗装置。该产品具有更高的抗血栓性和优化的编织设计，使医生能够以更少的干预实现更佳的手术效果。结合史赛克的培训和医生支援计划，该产品可提供无缝的临床体验。 Surpass 精英血流导向装置可提高病患安全性，简化手术流程，并支持在神经血管手术中更广泛地采用血流导向疗法。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球神经血管栓塞器材市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧和自主智能
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 血流晶粒支架的应用日益增多
    • 液体栓塞系统的使用日益增多
    • 人们越来越倾向选择微创介入神经放射学介入治疗
    • 扩展先进涂层卷材技术
    • 人们越来越重视精密神经血管装置

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 神经科专科诊所
  • 神经血管研究所
  • 中风护理中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球神经血管栓塞器械市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球神经血管栓塞器材市场规模、对比及成长率分析
  • 全球神经栓塞器材市场表现：规模与成长，2020-2025年
  • 全球神经栓塞器材市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 栓塞弹簧圈、液体栓塞系统、血流导引支架、动脉瘤夹及其他产品
  • 透过治疗
  • 神经血管出血管理，出血性中风治疗方案
  • 指示
  • 脑动脉瘤、动静脉畸形及其他适应症
  • 最终用户
  • 医院、门诊手术中心和其他最终用户
  • 依类型细分：栓塞线圈
  • 落叶型线圈、裸铂线圈、水凝胶涂层线圈
  • 依类型细分：液体栓塞系统
  • 基于N-丁基氰基丙烯酸酯的栓塞材料，Onyx液体栓塞系统
  • 按类型细分：血流导向支架
  • 采用双层技术的支架，用于治疗动脉瘤的血流导向装置
  • 依类型细分：动脉瘤夹
  • 钛合金夹子，不銹钢夹子
  • 按类型细分：其他产品
  • 栓塞球囊、微导管

第十章 区域与国家分析

  • 全球神经栓塞器材市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球神经栓塞器材市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 神经栓塞器材市场：竞争格局及市场占有率（2024年）
  • 神经栓塞器材市场：公司估值矩阵
  • 神经栓塞器材市场：公司概况
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Stryker Corporation
    • Boston Scientific Corporation

第37章：其他领先和创新企业

  • Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年神经栓塞器材市场：提供新机会的国家
  • 2030年神经血管栓塞器材市场：充满新机会的细分市场
  • 2030年神经栓塞器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MNEDM01_G26Q1

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

Tariffs are impacting the neurovascular embolization devices market by increasing costs of imported platinum coils, nitinol stents, microcatheters, polymers, and precision-manufactured components used in embolization systems. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on specialized imported materials, while Asia-Pacific faces higher costs for device exports and component sourcing. These tariffs are raising device prices and impacting procurement budgets for neurointerventional procedures. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of high-value neurovascular devices.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including neurovascular embolization devices industry global market size, regional shares, competitors with a neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. This neurovascular embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of cerebral aneurysms, expansion of neurointerventional procedures, increasing availability of skilled neurovascular specialists, growing hospital investments in advanced neurocare, wider adoption of minimally invasive stroke treatments.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising investments in neurovascular R&D, expansion of aging population with vascular disorders, growing adoption of next-generation embolization devices, increasing focus on improving procedural outcomes. Major trends in the forecast period include increasing adoption of flow diversion stents, rising use of liquid embolic systems, growing preference for minimally invasive neurointerventions, expansion of coil technologies with advanced coatings, enhanced focus on precision neurovascular devices.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Leading companies in the neurovascular embolization devices market are focusing on developing advanced solutions, such as next-generation flow diverters, to replace traditional aneurysm treatment methods. A next-generation flow diverter is a device designed to enhance procedural safety and effectiveness by improving vessel wall apposition, reducing clotting risk, and enabling easier deployment in complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter as part of its neurovascular portfolio. This innovation replaces older aneurysm treatment devices by offering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It features improved thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. When integrated with Stryker's training and physician support programs, it provides a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, streamlines procedural workflows, and supports wider adoption of flow diversion therapy in neurovascular care.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc

North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Neurovascular Hemorrhage Management; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Embolization Coils: Detachable Coils; Bare Platinum Coils; Coils With Hydrogel Coatings
  • 2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics; Onyx Liquid Embolic System
  • 3) By Flow Diversion Stents: Stents With Dual-Layer Technology; Flow Diverters For Aneurysm Treatment
  • 4) By Aneurysm Clips: Titanium Clips; Stainless Steel Clips
  • 5) By Other Products: Balloons For Embolization; Microcatheters
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Kaneka Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical LLC; Integer Holdings Corporation; Merit Medical Systems Inc; Penumbra Inc; Asahi Intecc Co Ltd; MicroVention Inc; Balt USA LLC; Imperative Care Inc; Acandis GmbH & Co KG; Rapid Medical Ltd; Vesalio LLC; Phenox GmbH; Cerenovus; Sequent Medical Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neurovascular Embolization Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neurovascular Embolization Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neurovascular Embolization Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neurovascular Embolization Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Flow Diversion Stents
    • 4.2.2 Rising Use Of Liquid Embolic Systems
    • 4.2.3 Growing Preference For Minimally Invasive Neurointerventions
    • 4.2.4 Expansion Of Coil Technologies With Advanced Coatings
    • 4.2.5 Enhanced Focus On Precision Neurovascular Devices

5. Neurovascular Embolization Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Neurology Clinics
  • 5.4 Neurovascular Research Institutes
  • 5.5 Stroke Care Centers

6. Neurovascular Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurovascular Embolization Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neurovascular Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neurovascular Embolization Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurovascular Embolization Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurovascular Embolization Devices Market Segmentation

  • 9.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
  • 9.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions
  • 9.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Brain Aneurysms, Arteriovenous Malformation, Other Indications
  • 9.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Other End Users
  • 9.5. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Embolization Coils, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
  • 9.6. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Liquid Embolic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System
  • 9.7. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Flow Diversion Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
  • 9.8. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Aneurysm Clips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Titanium Clips, Stainless Steel Clips
  • 9.9. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Balloons For Embolization, Microcatheters

10. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 10.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurovascular Embolization Devices Market

  • 11.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurovascular Embolization Devices Market

  • 12.1. China Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurovascular Embolization Devices Market

  • 13.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurovascular Embolization Devices Market

  • 14.1. Japan Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurovascular Embolization Devices Market

  • 15.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurovascular Embolization Devices Market

  • 16.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurovascular Embolization Devices Market

  • 17.1. South Korea Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurovascular Embolization Devices Market

  • 18.1. Taiwan Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurovascular Embolization Devices Market

  • 19.1. South East Asia Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurovascular Embolization Devices Market

  • 20.1. Western Europe Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurovascular Embolization Devices Market

  • 21.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurovascular Embolization Devices Market

  • 22.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurovascular Embolization Devices Market

  • 23.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurovascular Embolization Devices Market

  • 24.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurovascular Embolization Devices Market

  • 25.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurovascular Embolization Devices Market

  • 26.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurovascular Embolization Devices Market

  • 27.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurovascular Embolization Devices Market

  • 28.1. North America Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurovascular Embolization Devices Market

  • 29.1. USA Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurovascular Embolization Devices Market

  • 30.1. Canada Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurovascular Embolization Devices Market

  • 31.1. South America Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurovascular Embolization Devices Market

  • 32.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurovascular Embolization Devices Market

  • 33.1. Middle East Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurovascular Embolization Devices Market

  • 34.1. Africa Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurovascular Embolization Devices Market Regulatory and Investment Landscape

36. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 36.1. Neurovascular Embolization Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neurovascular Embolization Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neurovascular Embolization Devices Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH

38. Global Neurovascular Embolization Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

40. Neurovascular Embolization Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Neurovascular Embolization Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neurovascular Embolization Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neurovascular Embolization Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer